We recently published 10 Big Names With Explosive Growth. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Wednesday. Recursion Pharmaceuticals jumped by 16.44 percent on ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

More holidaymakers are turning to AI when planning or booking their trips, according to travel association ABTA. The body found that 8% of travellers were using AI - up from 4% last year - with ...

Singer Taylor Swift is facing backlash on social media for allegedly using artificial intelligence (AI) to generate videos used to promote her new album, The Life of a Showgirl. The videos are part of ...

Earlier this year, Apple introduced its Foundation Models framework during WWDC 2025, which allows developers to use the company’s local AI models to power features in their applications. The company ...

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

President Donald Trump speaks to a gathering of top U.S. military commanders at Marine Corps Base Quantico, Tuesday, Sept. 30, 2025, in Quantico, Virginia. (Evan Vucci/AP) President Donald Trump told ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

In recent days, Recursion Pharmaceuticals attracted heightened attention as traders responded to the stock’s very large short interest, alongside the announcement of a $12.5 million milestone payment ...

Recursion Pharmaceuticals (NASDAQ:RXRX), a $2.06 billion market cap biotech company, saw Chief Executive Officer Christopher Gibson sell 100,000 shares of Class A Common Stock on September 25, 2025, ...

President Trump plans to announce Monday that using Tylenol while pregnant could potentially raise the risk of developing autism, sources told The Post. The Trump administration is expected to start ...